Split-Dosing of COVID-19 Vaccines Provides Non-Inferior Antibody Responsiveness to Conventional Vaccine Dosing
coronavirus disease 2019 (COVID-19), messenger RNA (mRNA), polyethylene glycol (PEG), American College of Allergy, Asthma, and Immunology (ACAAI), Receptor Binding Domain Protein (RBD), Spike Protein 1 (S1), Nucleocapsid (N), mean fluorescent intensity (MFI), natural infection (NI), significant differences in mean (SEM), MMR (measles, mumps, rubella), inhaled corticosteroids (ICS)
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Amal Musa, Macy Wood, Andrew Rorie, Sara M. May, Joel Van De Graaff, Jill A. Poole Tags: Letters Source Type: research
More News: Allergy | Allergy & Immunology | Asthma | Coronavirus | Corticosteroid Therapy | Covid Vaccine | COVID-19 | Measles | Measles Vaccine | Mumps | Mumps Vaccine | Polyethylene Glycol | Rubella | Rubella Vaccine | Vaccines